The UK/ANZ [18] trial showed that TAM was more effective in reducing in-breast event among women aged over 60 or those with low-intermediate grade DCIS compared to those aged under 60 or those with high grade, although this difference may be due to differences in ER/PR status which was not available in this study. Here, PGR is linked to ductal breast carcinoma in situ.